Search Results - "Rosenbaum, A.N."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    The Effect of Continuous Flow Left Ventricular Assist Device (CF-LVAD) Implantation on Serum Uric Acid Levels by Rosenbaum, A.N, Duval, S, Khan, M.B, Pritzker, M, John, R, Eckman, P.M

    “…Purpose Hyperuricemia is common in patients with severe heart failure. Change in uric acid level following continuous flow ventricular assist device (CF-VAD)…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Exercise-Induced Hypoxemia Predicts Heart Failure Hospitalization and Death in Patients Supported with Left Ventricular Assist Devices by Koerber, D.M., Rosenbaum, A.N., Olson, T.P., Kushwaha, S., Stulak, J., Maltais, S., Behfar, A.

    “…Following implantation of continuous-flow left ventricular assist devices (CF-LVADs), mechanical offloading results in improved resting hemodynamics; however…”
    Get full text
    Journal Article
  6. 6

    Intrinsic Myocardial Function and Relationship with Left Ventricular Unloading in Patients Supported on CF-LVAD Therapy by Rosenbaum, A.N., Soldatova, A., Stulak, J.M., Clavell, A., Behfar, A.

    “…Despite strong interest in left ventricular recovery, no clinical data exist on the relationship between intrinsic myocardial function and reverse remodeling…”
    Get full text
    Journal Article
  7. 7

    HAS-BLED and CHA2DS2-VASc Scores as Predictors of Bleeding and Thrombotic Risk after HeartMate II Ventricular Assist Device Implantation by Koene, R.J., Adatya, S.N., Naksuk, N., Rosenbaum, A.N., John, R., Eckman, P.M.

    “…Bleeding and thromboembolic (TE) events are feared complications following continuous-flow ventricular assist device (CF-VAD) implant. Risk stratification may…”
    Get full text
    Journal Article
  8. 8

    HAS-BLED and CHA2 DS2 -VASc Scores as Predictors of Bleeding and Thrombotic Risk after HeartMate II Ventricular Assist Device Implantation by Koene, R.J, Adatya, S.N, Naksuk, N, Rosenbaum, A.N, John, R, Eckman, P.M

    “…Purpose Bleeding and thromboembolic (TE) events are feared complications following continuous-flow ventricular assist device (CF-VAD) implant. Risk…”
    Get full text
    Journal Article